English Deutsch 中文
XinTech
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
XinTech
Menu Deutsch 中文

Sihuan to Develop CNS Drugs with Dutch to-BBB

Dec. 11, 2013

to-BBB, the brain drug development company, announced its collaboration agreement with Sun Moral International (HK) Limited, a wholly owned subsidiary of the Sihuan Pharmaceutical Holdings Group. The agreement lays the foundation for collaborative research and development of innovative drugs for central nervous system diseases.

to-BBB and Sihuan will conduct feasibility studies by applying to-BBB’s G-Technology, a patented brain drug delivery technology for sustained release and enhanced brain delivery, to certain drug compounds owned by Sihuan.